[神経膠芽腫の患者における生存率に対するTumor Treating Field[腫瘍治療装置の名称]+テモゾロミド対テモゾロミド単独の効果:無作為化臨床試験] med. app.

Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.

掲載誌: JAMA 2017; 318 (23): 2306-2316

ばく露